Cart
sales@molnova.com
Selvigaltin
CAS No. 1978336-95-6
Selvigaltin( —— )
Catalog No. M35740 CAS No. 1978336-95-6
Selvigaltin (GB1211) is a Gal-3 inhibitor with potential anticancer activity. Selvigaltin is used in the study of cirrhosis and cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 656 | In Stock |
|
| 10MG | 1121 | In Stock |
|
| 25MG | 2366 | In Stock |
|
| 50MG | 3674 | In Stock |
|
| 100MG | 5543 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSelvigaltin
-
NoteResearch use only, not for human use.
-
Brief DescriptionSelvigaltin (GB1211) is a Gal-3 inhibitor with potential anticancer activity. Selvigaltin is used in the study of cirrhosis and cancer.
-
DescriptionSelvigaltin (GB1211) is an orally available galectin-3 (Gal-3) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetNeuropeptide Y Receptor
-
RecptorNeuropeptide Y Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1978336-95-6
-
Formula Weight533.32
-
Molecular FormulaC19H16BrF3N4O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 12.5 mg/mL (23.44 mM; Ultrasonic (<60°C)
-
SMILES[H][C@@]1([C@@H](O)[C@@H](CO)O[C@H](Sc2cncc(Br)c2)[C@@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Slack RJ, et al. The therapeutic potential of galectin-3 inhibition in fibrotic disease. Int J Biochem Cell Biol. 2021 Jan;130:105881. ?
molnova catalog
related products
-
BIBO 3304
BIBO 3304 is a potent, selective, nonpeptide neuropeptide Y Y1 receptor antagonist with IC50 of 0.38 and 0.72 nM for human and the rat Y1 receptor, respectively.
-
[D-Trp34]-Neuropepti...
Potent neuropeptide Y (NPY) Y5 receptor agonist (pEC50 values are 7.82, 6.28, 6.44 and > 6 at rat Y5, Y4, Y1 and Y2 receptors respectively) that displays > 26-fold, > 1000-fold and > 1000-fold selectivity over Y1, Y2 and Y4 receptors respectively. Induces hyperphagia, body weight gain, adiposity, hypercholesterolemia, hyperinsulinemia and hyperleptinemia in vivo. Orally active.
-
GW438014A
GW438014A is a potent, selective antagonist of the NPY-Y5 receptor, effectively inhibiting food consumption and curbing body weight gain in obese rodents.
